Septerna (SEPN) Accounts Payables (2023 - 2026)
Septerna's quarterly Accounts Payables came in at $7.5 million in Q1 2026, up 71.63% year-on-year from $4.3 million in Q1 2025, and down 27.41% quarter-over-quarter from $10.3 million in Q4 2025.
Septerna has reported Accounts Payables for 4 years, with the latest figure at $7.5 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 71.63% year-over-year to $7.5 million; the trailing twelve-month figure through Mar 2026 stood at $7.5 million (up 71.63% YoY), and the FY2025 full-year result was $10.3 million, up 221.34% from the prior year.
- Accounts Payables for Q1 2026 stood at $7.5 million, down from $10.3 million in the prior quarter.
- The five-year high for Accounts Payables was $10.3 million in Q4 2025, with the low at $2.6 million in Q4 2023.
- Average Accounts Payables over 4 years is $5.5 million, with a median of $5.2 million recorded in 2024.
- Peak annual rise in Accounts Payables reached 221.34% in 2025, while the deepest fall reached 39.15% in 2025.
- Tracing SEPN's Accounts Payables over 4 years: stood at $2.6 million in 2023, then rose by 21.35% to $3.2 million in 2024, then soared by 221.34% to $10.3 million in 2025, then retreated by 27.41% to $7.5 million in 2026.
- The last three Accounts Payables figures came in at $7.5 million (Q1 2026), $10.3 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | 7.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.46 Mn |
| Dec 31, 2025 | 10.28 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | 6.54 Mn |
| Mar 31, 2025 | 4.35 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 6.13 Mn |
| Dec 31, 2023 | 2.64 Mn |